Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Goodbye Johnny

<< Previous

Bullboard Posts

Next >>

Comment by Snowdrifton Aug 12, 2024 7:28pm

63 Views

Post# 36175548

RE:Goodbye Johnny

CEO of which two companies?

Rigbey is on the board of directors of Oncolytics and of IM Therapeutics.

And now he's also CEO of Cernova.

Quentin30 wrote: Can Mr Rigby be CEO of two companies concurrently.?? Not saying he's left ONCY, but probably got bored watching the tumbleweed blowing through the Calgary offices... and decided he needed another challenge...

Market seems to think its negative news... but nevermind... after 25 years of buying opporunties, here's another one.

If Dr Heineken doesn't provide substantial details on Phase III and or mBC data, then I see this dropping even further after tomorrow's fireside chat.

good luck to all of you still holding... you need it.